A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata

Zoltán Trizna, Tanya Evans, Suzanne Bruce, Kenneth D Hatch, Stephen K. Tyring

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Interferon (IFN) alpha and IFN gamma have synergistic in vitro and in vivo effects and have each been used in the treatment of anogenital condylomata acuminata. Study Goals: To compare the efficacy and safety of regional 3 X 106 U IFN alpha (Group A), 3 x 106 U IFN gamma (Group B), 1.5 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group C), and 3 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group D) in the treatment of recalcitrant anogenital condylomata acuminata. Study Design: Six-week courses of regional IFNs were administered in a randomized, double-blind, multicenter study. Response was assessed as change in the total area affected by condylomata. Results: The treatments of Groups A, B, and C were similarly effective (complete response in 13.6%, 18.5%, and 16.0%, respectively). Group D had the lowest rate of complete response (3.8%), but this combination was the most effective when partial and complete responses were combined (73.0%). Conclusion: Regional IFN is a moderately effective and safe treatment in patients with recalcitrant anogenital condylomata acuminata. Combinations of IFNs alpha and gamma were not superior to IFN monotherapy.

Original languageEnglish (US)
Pages (from-to)361-365
Number of pages5
JournalSexually Transmitted Diseases
Volume25
Issue number7
DOIs
StatePublished - Aug 1998

Fingerprint

Condylomata Acuminata
Interferon-alpha
Interferons
Interferon-gamma
Therapeutics
Double-Blind Method
Multicenter Studies
Safety

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)

Cite this

A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata. / Trizna, Zoltán; Evans, Tanya; Bruce, Suzanne; Hatch, Kenneth D; Tyring, Stephen K.

In: Sexually Transmitted Diseases, Vol. 25, No. 7, 08.1998, p. 361-365.

Research output: Contribution to journalArticle

@article{3d7deb2619a94311bfb5f4d0d785bd7a,
title = "A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata",
abstract = "Background: Interferon (IFN) alpha and IFN gamma have synergistic in vitro and in vivo effects and have each been used in the treatment of anogenital condylomata acuminata. Study Goals: To compare the efficacy and safety of regional 3 X 106 U IFN alpha (Group A), 3 x 106 U IFN gamma (Group B), 1.5 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group C), and 3 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group D) in the treatment of recalcitrant anogenital condylomata acuminata. Study Design: Six-week courses of regional IFNs were administered in a randomized, double-blind, multicenter study. Response was assessed as change in the total area affected by condylomata. Results: The treatments of Groups A, B, and C were similarly effective (complete response in 13.6{\%}, 18.5{\%}, and 16.0{\%}, respectively). Group D had the lowest rate of complete response (3.8{\%}), but this combination was the most effective when partial and complete responses were combined (73.0{\%}). Conclusion: Regional IFN is a moderately effective and safe treatment in patients with recalcitrant anogenital condylomata acuminata. Combinations of IFNs alpha and gamma were not superior to IFN monotherapy.",
author = "Zolt{\'a}n Trizna and Tanya Evans and Suzanne Bruce and Hatch, {Kenneth D} and Tyring, {Stephen K.}",
year = "1998",
month = "8",
doi = "10.1097/00007435-199808000-00007",
language = "English (US)",
volume = "25",
pages = "361--365",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata

AU - Trizna, Zoltán

AU - Evans, Tanya

AU - Bruce, Suzanne

AU - Hatch, Kenneth D

AU - Tyring, Stephen K.

PY - 1998/8

Y1 - 1998/8

N2 - Background: Interferon (IFN) alpha and IFN gamma have synergistic in vitro and in vivo effects and have each been used in the treatment of anogenital condylomata acuminata. Study Goals: To compare the efficacy and safety of regional 3 X 106 U IFN alpha (Group A), 3 x 106 U IFN gamma (Group B), 1.5 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group C), and 3 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group D) in the treatment of recalcitrant anogenital condylomata acuminata. Study Design: Six-week courses of regional IFNs were administered in a randomized, double-blind, multicenter study. Response was assessed as change in the total area affected by condylomata. Results: The treatments of Groups A, B, and C were similarly effective (complete response in 13.6%, 18.5%, and 16.0%, respectively). Group D had the lowest rate of complete response (3.8%), but this combination was the most effective when partial and complete responses were combined (73.0%). Conclusion: Regional IFN is a moderately effective and safe treatment in patients with recalcitrant anogenital condylomata acuminata. Combinations of IFNs alpha and gamma were not superior to IFN monotherapy.

AB - Background: Interferon (IFN) alpha and IFN gamma have synergistic in vitro and in vivo effects and have each been used in the treatment of anogenital condylomata acuminata. Study Goals: To compare the efficacy and safety of regional 3 X 106 U IFN alpha (Group A), 3 x 106 U IFN gamma (Group B), 1.5 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group C), and 3 x 106 U IFN alpha plus 1.5 x 106 U IFN gamma (Group D) in the treatment of recalcitrant anogenital condylomata acuminata. Study Design: Six-week courses of regional IFNs were administered in a randomized, double-blind, multicenter study. Response was assessed as change in the total area affected by condylomata. Results: The treatments of Groups A, B, and C were similarly effective (complete response in 13.6%, 18.5%, and 16.0%, respectively). Group D had the lowest rate of complete response (3.8%), but this combination was the most effective when partial and complete responses were combined (73.0%). Conclusion: Regional IFN is a moderately effective and safe treatment in patients with recalcitrant anogenital condylomata acuminata. Combinations of IFNs alpha and gamma were not superior to IFN monotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0031870948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031870948&partnerID=8YFLogxK

U2 - 10.1097/00007435-199808000-00007

DO - 10.1097/00007435-199808000-00007

M3 - Article

C2 - 9713916

AN - SCOPUS:0031870948

VL - 25

SP - 361

EP - 365

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 7

ER -